NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.
- DOI
- 10.1016/j.esmoop.2025.106043
- Published
- 2026 Mar
- Container
- ESMO open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.esmoop.2025.106043,
title = {NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.},
author = {Macarulla T and Cid RP and Womack MS and Gracian AC and Zervoudakis A and Hatoum H and Chung V and Patel A and Paulson AS and Pant S and O'Reilly EM and Hubner RA and Van Cutsem E and Bekaii-Saab T and Zhang L and Li J and Chen H and Maxwell F and Wainberg ZA and Melisi D},
year = {2026},
journal = {ESMO open},
doi = {10.1016/j.esmoop.2025.106043},
url = {https://doi.org/10.1016/j.esmoop.2025.106043}
}RIS
TY - JOUR TI - NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial. AU - Macarulla T AU - Cid RP AU - Womack MS AU - Gracian AC AU - Zervoudakis A AU - Hatoum H AU - Chung V AU - Patel A AU - Paulson AS AU - Pant S AU - O'Reilly EM AU - Hubner RA AU - Van Cutsem E AU - Bekaii-Saab T AU - Zhang L AU - Li J AU - Chen H AU - Maxwell F AU - Wainberg ZA AU - Melisi D PY - 2026 JO - ESMO open DO - 10.1016/j.esmoop.2025.106043 UR - https://doi.org/10.1016/j.esmoop.2025.106043 ER -
APA
T, M., RP, C., MS, W., AC, G., A, Z., H, H., V, C., A, P., AS, P., S, P., EM, O., RA, H., E, V. C., T, B., L, Z., J, L., H, C., F, M., ZA, W., & D, M. (2026). NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial.. ESMO open. https://doi.org/10.1016/j.esmoop.2025.106043
Source records
- pubmed · retrieved 2026-09-26T21:49:24.454Z